No insider purchase over the last 90 days. The latest, by Silchester International Investors LLP, was filed 22 Apr 2024.
Santen Pharmaceutical Co.,Ltd.: what insiders have been doing
Santen Pharmaceutical Co.,Ltd., founded in 1890, is a Banks company based in Osaka, Japan. Its directors and officers file their transactions with EDINET (Japan FSA). Over the twelve months to 26 October 2026, 1 filing were filed, from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
There has been no open-market purchase by an insider of Santen Pharmaceutical Co.,Ltd. for at least a year.
For context, the typical company on the same exchange (median of 3,205 companies) published 3 filings over the same period, against 1 filing here. The full history, which starts in 2021, counts 25 purchases against 21 sales.
Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -5.7%Entry JP¥1,505 · Close at T+365 JP¥1,419
- Unknown-18.8%Entry JP¥1,398 · Close at T+365 JP¥1,135
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Santen Pharmaceutical Co.,Ltd. Buy (bullish), based on 9 analysts. Average price target: JP¥2,378.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- ShareXTKSEDINET:S100Z9VH
- 20.6% of flowShareXTKSEDINET:S100WU0G
- 18.4% of flowShareXTKSEDINET:S100WQ8Q
- ShareXTKSEDINET:S100WPCC
- 16.9% of flowShareXTKSEDINET:S100VFQF
- 17.4% of flowShareXTKSEDINET:S100VCI4
- 14.9% of flowShareXTKSEDINET:S100V7FC
- ShareXTKSEDINET:S100UW8X
- ShareXTKSEDINET:S100UJI2
- ShareXTKSEDINET:S100U3FP
- ShareXTKSEDINET:S100TKFI
- 11.8% of flowShareXTKSEDINET:S100TB1B
- 49,600 sharesShareXTKSEDINET:S100TB1B:T1Canonical exit: 20 Jun 2024 (T+90)
- 4,700 shares@ JP¥1,458.001.3% of flowShareXOFFEDINET:S100TB1B:T2Canonical exit: 20 Jun 2024 (T+90)
- 500 shares@ JP¥1,475.00080.1% of flowShareXOFFEDINET:S100TB1B:T4Canonical exit: 23 Jun 2024 (T+90)
- 1,300 sharesShareXTKSEDINET:S100TB1B:T3Canonical exit: 23 Jun 2024 (T+90)
- 1,700 sharesShareXTKSEDINET:S100TB1B:T5Canonical exit: 24 Jun 2024 (T+90)
- 800 shares@ JP¥1,472.99930.2% of flowShareXOFFEDINET:S100TB1B:T6Canonical exit: 24 Jun 2024 (T+90)
- 23,800 sharesShareXTKSEDINET:S100TB1B:T7Canonical exit: 2 Jul 2024 (T+90)
- 330,100 sharesShareXTKSEDINET:S100TB1B:T9Canonical exit: 3 Jul 2024 (T+90)
- 123,200 sharesShareXTKSEDINET:S100TB1B:T11Canonical exit: 4 Jul 2024 (T+90)
- 25,200 shares@ JP¥1,456.007.1% of flowShareXOFFEDINET:S100TB1B:T12Canonical exit: 4 Jul 2024 (T+90)
- 121,700 sharesShareXTKSEDINET:S100TB1B:T13Canonical exit: 11 Jul 2024 (T+90)
- 311,400 sharesShareXTKSEDINET:S100TB1B:T15Canonical exit: 18 Jul 2024 (T+90)
- 138,600 shares@ JP¥1,448.0038.9% of flowShareXOFFEDINET:S100TB1B:T16Canonical exit: 18 Jul 2024 (T+90)
25 of 78 declarations
About Santen Pharmaceutical Co.,Ltd.
Santen Pharmaceutical Co., Ltd. is a Japanese company specializing in the pharmaceutical sector, providing health and eye care products. It is listed on the Tokyo Stock Exchange under the symbol XTKS.
